Logo image of 1EL.MI

ESSILORLUXOTTICA (1EL.MI) Stock Fundamental Analysis

Europe - BIT:1EL - FR0000121667 - Common Stock

317.8 EUR
-1.9 (-0.59%)
Last: 10/31/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to 1EL. 1EL was compared to 60 industry peers in the Health Care Equipment & Supplies industry. 1EL has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1EL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

1EL had positive earnings in the past year.
1EL had a positive operating cash flow in the past year.
In the past 5 years 1EL has always been profitable.
1EL had a positive operating cash flow in each of the past 5 years.
1EL.MI Yearly Net Income VS EBIT VS OCF VS FCF1EL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.84%, 1EL is in line with its industry, outperforming 58.33% of the companies in the same industry.
With a Return On Equity value of 6.29%, 1EL perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
1EL has a Return On Invested Capital of 5.39%. This is comparable to the rest of the industry: 1EL outperforms 53.33% of its industry peers.
1EL had an Average Return On Invested Capital over the past 3 years of 4.84%. This is below the industry average of 9.00%.
The 3 year average ROIC (4.84%) for 1EL is below the current ROIC(5.39%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.84%
ROE 6.29%
ROIC 5.39%
ROA(3y)3.67%
ROA(5y)2.72%
ROE(3y)5.86%
ROE(5y)4.39%
ROIC(3y)4.84%
ROIC(5y)3.74%
1EL.MI Yearly ROA, ROE, ROIC1EL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 8.74%, 1EL is in the better half of the industry, outperforming 61.67% of the companies in the same industry.
1EL's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 12.86%, 1EL is in the better half of the industry, outperforming 61.67% of the companies in the same industry.
In the last couple of years the Operating Margin of 1EL has grown nicely.
1EL's Gross Margin of 61.91% is fine compared to the rest of the industry. 1EL outperforms 65.00% of its industry peers.
In the last couple of years the Gross Margin of 1EL has remained more or less at the same level.
Industry RankSector Rank
OM 12.86%
PM (TTM) 8.74%
GM 61.91%
OM growth 3Y4.69%
OM growth 5Y6.47%
PM growth 3Y6.8%
PM growth 5Y7.52%
GM growth 3Y0.88%
GM growth 5Y0.39%
1EL.MI Yearly Profit, Operating, Gross Margins1EL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

1EL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
1EL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1EL has more shares outstanding
Compared to 1 year ago, 1EL has a worse debt to assets ratio.
1EL.MI Yearly Shares Outstanding1EL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
1EL.MI Yearly Total Debt VS Total Assets1EL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

An Altman-Z score of 4.63 indicates that 1EL is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.63, 1EL is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
1EL has a debt to FCF ratio of 4.18. This is a neutral value as 1EL would need 4.18 years to pay back of all of its debts.
1EL has a better Debt to FCF ratio (4.18) than 66.67% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that 1EL is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.25, 1EL perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.18
Altman-Z 4.63
ROIC/WACC0.69
WACC7.82%
1EL.MI Yearly LT Debt VS Equity VS FCF1EL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

A Current Ratio of 0.97 indicates that 1EL may have some problems paying its short term obligations.
The Current ratio of 1EL (0.97) is worse than 80.00% of its industry peers.
1EL has a Quick Ratio of 0.97. This is a bad value and indicates that 1EL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of 1EL (0.67) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.67
1EL.MI Yearly Current Assets VS Current Liabilites1EL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.00% over the past year.
The Earnings Per Share has been growing by 16.01% on average over the past years. This is quite good.
1EL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.45%.
1EL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.80% yearly.
EPS 1Y (TTM)3%
EPS 3Y13.7%
EPS 5Y16.01%
EPS Q2Q%2.1%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y10.18%
Revenue growth 5Y8.8%
Sales Q2Q%5.52%

3.2 Future

Based on estimates for the next years, 1EL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.20% on average per year.
1EL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.39% yearly.
EPS Next Y6.78%
EPS Next 2Y8.91%
EPS Next 3Y9.98%
EPS Next 5Y9.2%
Revenue Next Year4.62%
Revenue Next 2Y5.36%
Revenue Next 3Y5.93%
Revenue Next 5Y6.39%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1EL.MI Yearly Revenue VS Estimates1EL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
1EL.MI Yearly EPS VS Estimates1EL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 46.26, the valuation of 1EL can be described as expensive.
1EL's Price/Earnings ratio is in line with the industry average.
1EL is valuated expensively when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 39.46, the valuation of 1EL can be described as expensive.
Based on the Price/Forward Earnings ratio, 1EL is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.55, 1EL is valued quite expensively.
Industry RankSector Rank
PE 46.26
Fwd PE 39.46
1EL.MI Price Earnings VS Forward Price Earnings1EL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

1EL's Enterprise Value to EBITDA ratio is in line with the industry average.
1EL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 43.77
EV/EBITDA 23.84
1EL.MI Per share data1EL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1EL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6.83
PEG (5Y)2.89
EPS Next 2Y8.91%
EPS Next 3Y9.98%

5

5. Dividend

5.1 Amount

1EL has a Yearly Dividend Yield of 1.24%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.13, 1EL pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.37, 1EL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.24%

5.2 History

The dividend of 1EL has a limited annual growth rate of 4.50%.
Dividend Growth(5Y)4.5%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

22.97% of the earnings are spent on dividend by 1EL. This is a low number and sustainable payout ratio.
1EL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.97%
EPS Next 2Y8.91%
EPS Next 3Y9.98%
1EL.MI Yearly Income VS Free CF VS Dividend1EL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
1EL.MI Dividend Payout.1EL.MI Dividend Payout, showing the Payout Ratio.1EL.MI Dividend Payout.PayoutRetained Earnings

ESSILORLUXOTTICA

BIT:1EL (10/31/2025, 7:00:00 PM)

317.8

-1.9 (-0.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-16 2025-10-16
Earnings (Next)02-03 2026-02-03/amc
Inst Owners29.19%
Inst Owner ChangeN/A
Ins Owners32.47%
Ins Owner ChangeN/A
Market Cap147.19B
Revenue(TTM)27.24B
Net Income(TTM)2.38B
Analysts78.67
Price Target314.87 (-0.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.24%
Yearly Dividend2.56
Dividend Growth(5Y)4.5%
DP22.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.75%
PT rev (3m)14.07%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.53%
Valuation
Industry RankSector Rank
PE 46.26
Fwd PE 39.46
P/S 5.4
P/FCF 43.77
P/OCF 29.95
P/B 3.89
P/tB N/A
EV/EBITDA 23.84
EPS(TTM)6.87
EY2.16%
EPS(NY)8.05
Fwd EY2.53%
FCF(TTM)7.26
FCFY2.28%
OCF(TTM)10.61
OCFY3.34%
SpS58.82
BVpS81.67
TBVpS-5.08
PEG (NY)6.83
PEG (5Y)2.89
Graham Number112.36
Profitability
Industry RankSector Rank
ROA 3.84%
ROE 6.29%
ROCE 6.93%
ROIC 5.39%
ROICexc 5.71%
ROICexgc 35.85%
OM 12.86%
PM (TTM) 8.74%
GM 61.91%
FCFM 12.34%
ROA(3y)3.67%
ROA(5y)2.72%
ROE(3y)5.86%
ROE(5y)4.39%
ROIC(3y)4.84%
ROIC(5y)3.74%
ROICexc(3y)5.06%
ROICexc(5y)3.96%
ROICexgc(3y)34.05%
ROICexgc(5y)28.3%
ROCE(3y)6.22%
ROCE(5y)4.81%
ROICexgc growth 3Y0.01%
ROICexgc growth 5Y9.27%
ROICexc growth 3Y12.06%
ROICexc growth 5Y11.05%
OM growth 3Y4.69%
OM growth 5Y6.47%
PM growth 3Y6.8%
PM growth 5Y7.52%
GM growth 3Y0.88%
GM growth 5Y0.39%
F-Score7
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.18
Debt/EBITDA 1.41
Cap/Depr 49.38%
Cap/Sales 5.69%
Interest Coverage 250
Cash Conversion 73.95%
Profit Quality 141.24%
Current Ratio 0.97
Quick Ratio 0.67
Altman-Z 4.63
F-Score7
WACC7.82%
ROIC/WACC0.69
Cap/Depr(3y)51.19%
Cap/Depr(5y)45.17%
Cap/Sales(3y)6.06%
Cap/Sales(5y)5.58%
Profit Quality(3y)145.59%
Profit Quality(5y)677.55%
High Growth Momentum
Growth
EPS 1Y (TTM)3%
EPS 3Y13.7%
EPS 5Y16.01%
EPS Q2Q%2.1%
EPS Next Y6.78%
EPS Next 2Y8.91%
EPS Next 3Y9.98%
EPS Next 5Y9.2%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y10.18%
Revenue growth 5Y8.8%
Sales Q2Q%5.52%
Revenue Next Year4.62%
Revenue Next 2Y5.36%
Revenue Next 3Y5.93%
Revenue Next 5Y6.39%
EBIT growth 1Y6.6%
EBIT growth 3Y15.34%
EBIT growth 5Y15.84%
EBIT Next Year56.93%
EBIT Next 3Y22.99%
EBIT Next 5Y16.01%
FCF growth 1Y3.16%
FCF growth 3Y-1.57%
FCF growth 5Y6.95%
OCF growth 1Y2.06%
OCF growth 3Y2.36%
OCF growth 5Y8.12%

ESSILORLUXOTTICA / 1EL.MI FAQ

What is the fundamental rating for 1EL stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1EL.MI.


What is the valuation status for 1EL stock?

ChartMill assigns a valuation rating of 2 / 10 to ESSILORLUXOTTICA (1EL.MI). This can be considered as Overvalued.


What is the profitability of 1EL stock?

ESSILORLUXOTTICA (1EL.MI) has a profitability rating of 6 / 10.


What is the valuation of ESSILORLUXOTTICA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ESSILORLUXOTTICA (1EL.MI) is 46.26 and the Price/Book (PB) ratio is 3.89.


What is the expected EPS growth for ESSILORLUXOTTICA (1EL.MI) stock?

The Earnings per Share (EPS) of ESSILORLUXOTTICA (1EL.MI) is expected to grow by 6.78% in the next year.